Answers are grounded in this paper and cite their sources.
ICU-acquired weakness is a frequent complication of critical illness. It is unclear whether it is a marker or mediator of poor outcomes. We aimed to determine acute and long-term outcomes and costs of ICU-acquired weakness among long-stay (≥8 days) ICU patients and to assess the impact of recovery of weakness at ICU discharge.
No takes yet. Share an insight, caveat, or question.
Hermans et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: